Philippe Wolgen
Chief Executive Officer at CLINUVEL PHARMACEUTICALS LIMITED
Net worth: 32 M $ as of 31/03/2024
Profile
Philippe Jacques Wolgen is currently the Chief Executive Officer, MD & Director at Clinuvel Pharmaceuticals Ltd.
and also serves as a Director at Clinuvel (UK) Ltd.
He holds an MBA from The Trustees of Columbia University in The City of New York and London Business School, and a doctorate from the University of Utrecht.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 24/11/2023 | 3,425,222 ( 6.83% ) | 32 M $ | 31/03/2024 |
Philippe Wolgen active positions
| Companies | Position | Start |
|---|---|---|
| CLINUVEL PHARMACEUTICALS LIMITED | Chief Executive Officer | 01/11/2005 |
Clinuvel (UK) Ltd.
 Clinuvel (UK) Ltd. BiotechnologyHealth Technology Part of Clinuvel Pharmaceuticals Ltd., Clinuvel (UK) Ltd. is a British company founded in 2005 that provides research and development in the field of biotechnology. The private company is based in London, UK. | Director/Board Member | 25/11/2005 |
Training of Philippe Wolgen
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
| University of Utrecht | Doctorate Degree |
| London Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CLINUVEL PHARMACEUTICALS LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
Clinuvel (UK) Ltd.
Clinuvel (UK) Ltd. BiotechnologyHealth Technology Part of Clinuvel Pharmaceuticals Ltd., Clinuvel (UK) Ltd. is a British company founded in 2005 that provides research and development in the field of biotechnology. The private company is based in London, UK. | Health Technology |
- Stock Market
- Insiders
- Philippe Wolgen
